Showing results (71-80 of 89) with videos related to
Sort By:
Pageof 9
Biometrics|April 29, 2026
Bayesian adaptive randomization in the I-SPY2 sequential multiple assignment randomized trialPeter Norwood, Christina Yau, Denise Wolf, et al.The New England Journal of Medicine|September 5, 2008
Quality of life with defibrillator therapy or amiodarone in heart failureDaniel B Mark, Kevin J Anstrom, Jie L Sun, et al.NEJM Evidence|February 6, 2024
Monitoring Multiple U.S. Government-Supported Covid-19 Vaccine TrialsSally Hunsberger, Susan S Ellenberg, Steven Joffe, et al.The Journal of Infectious Diseases|May 19, 2021
Data and Safety Monitoring of COVID-19 Vaccine Clinical TrialsSteven Joffe, Abdel Babiker, Susan S Ellenberg, et al.Epilepsia|January 24, 2026
mHealth adherence in pediatric epilepsy: Outcomes of a sequential, multiple assignment, randomized trial (SMART)Avani C Modi, Janelle L Wagner, Anup D Patel, et al.Journal of Medical Systems|June 4, 2005
Surgeons' economic profiles: can we get the "right" answers?Eric L Eisenstein, Charles F Bethea, Lawrence H Muhlbaier, et al.Statistics in Medicine|October 29, 2015
Using pilot data to size a two-arm randomized trial to find a nearly optimal personalized treatment strategyEric B Laber, Ying-Qi Zhao, Todd Regh, et al.The American Journal of Cardiology|October 7, 2004
Optimal duration of eptifibatide infusion in percutaneous coronary intervention (an ESPRIT substudy)Abdallah G Rebeiz, Jean-Pierre Dery, Anastasios A Tsiatis, et al.Circulation|July 5, 2006
Cost-effectiveness of defibrillator therapy or amiodarone in chronic stable heart failure: results from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT)Daniel B Mark, Charlotte L Nelson, Kevin J Anstrom, et al.American Heart Journal|May 3, 2005
Conducting economic evaluations alongside multinational clinical trials: toward a research consensusShelby D Reed, Kevin J Anstrom, Ameet Bakhai, et al.Pageof 9